BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatosis
1
Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
8/7/2019 7:09:17 AM | Browse: 218 | Download: 160
2
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 177 | Download: 90
3
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 242 | Download: 274
4
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 254 | Download: 181
5
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 294 | Download: 193
6
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
1/21/2019 5:38:30 AM | Browse: 281 | Download: 195
7
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 368 | Download: 252
8
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 268 | Download: 185
9
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
9/25/2018 3:44:36 AM | Browse: 301 | Download: 292
10
Feasibility of using marginal liver grafts in living donor liver transplantation
6/15/2018 9:13:16 AM | Browse: 348 | Download: 223
11
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 412 | Download: 194
12
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 430 | Download: 246
13
circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
1/19/2018 9:46:49 AM | Browse: 410 | Download: 272
14
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 455 | Download: 649
15
Non-alcoholic fatty liver disease: An expanded review
6/6/2017 12:54:56 AM | Browse: 650 | Download: 323
16
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
5/20/2017 12:26:24 PM | Browse: 500 | Download: 367
17
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
5/16/2017 6:56:36 AM | Browse: 743 | Download: 893
18
Non-alcoholic fatty liver disease and cardiovascular risk
5/16/2017 6:56:36 AM | Browse: 659 | Download: 377
19
Changes in human hepatic metabolism in steatosis and cirrhosis
4/20/2017 3:58:56 PM | Browse: 909 | Download: 704
20
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
1/19/2017 11:16:00 AM | Browse: 803 | Download: 562
21
Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
12/27/2016 8:31:00 AM | Browse: 392 | Download: 530
22
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 554 | Download: 597
23
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
11/6/2016 3:43:00 PM | Browse: 665 | Download: 343
24
Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease
9/22/2016 9:52:00 AM | Browse: 701 | Download: 787
25
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease
3/29/2016 3:29:00 PM | Browse: 676 | Download: 1092
26
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver
1/26/2016 6:22:00 PM | Browse: 761 | Download: 889
27
Mechanisms of intrahepatic triglyceride accumulation
1/20/2016 5:04:00 PM | Browse: 707 | Download: 533
28
Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis
12/4/2015 3:24:00 PM | Browse: 676 | Download: 699
29
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
12/2/2015 12:20:00 PM | Browse: 743 | Download: 484
30
Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan®)
11/11/2015 1:33:00 PM | Browse: 792 | Download: 720
31
Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice
10/30/2015 11:57:00 AM | Browse: 549 | Download: 991
32
Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
9/9/2015 2:44:00 PM | Browse: 772 | Download: 772
33
MicroRNA-185-5p mediates the regulation of SREBP2 expression by hepatitis C virus core protein
4/30/2015 2:11:00 PM | Browse: 454 | Download: 830
34
Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease
4/14/2015 6:13:00 PM | Browse: 765 | Download: 554
35
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease
12/10/2014 3:50:00 PM | Browse: 814 | Download: 666
36
Red cell distribution width and nonalcoholic steatohepatitis
12/5/2014 11:43:00 AM | Browse: 456 | Download: 443
37
Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
12/2/2014 10:47:00 AM | Browse: 897 | Download: 753
38
Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies
11/10/2014 7:09:00 PM | Browse: 582 | Download: 377
39
Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease
10/29/2014 7:34:00 PM | Browse: 536 | Download: 480
40
Non-invasive diagnosis of alcoholic liver disease
10/29/2014 7:34:00 PM | Browse: 978 | Download: 507
41
Nonalcoholic fatty liver disease and vascular disease: State-of-the-art
10/7/2014 5:32:00 PM | Browse: 1006 | Download: 734
42
Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation
10/1/2014 8:25:00 PM | Browse: 861 | Download: 305
43
Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
10/1/2014 8:25:00 PM | Browse: 993 | Download: 648
44
Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review
9/18/2014 7:49:00 PM | Browse: 665 | Download: 729
45
Strategies to rescue steatotic livers before transplantation in clinical and experimental studies
9/15/2014 8:54:00 PM | Browse: 609 | Download: 484
46
PNPLA3 I148M polymorphism and progressive liver disease
9/12/2014 8:41:00 PM | Browse: 886 | Download: 290
47
Insight into the diagnosis and pathogenesis of hepatitis C virus infection
9/11/2014 8:40:00 PM | Browse: 1037 | Download: 686
48
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
9/10/2014 7:22:00 PM | Browse: 816 | Download: 520
49
Lipotoxicity in the liver
9/10/2014 5:06:00 PM | Browse: 695 | Download: 447
50
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
9/4/2014 3:52:00 PM | Browse: 544 | Download: 498